Deo Wabwire is an internist at MU-JHU Care Ltd. He has been involved in perinatal HIV prevention studies since 2002 and more recently pharmacokinetic studies in pregnant women. He has been a co-investigator for multiple NIH network supported studies.
He was the medical director for the MTCT plus antiretroviral treatment program and has continued to provide HIV care and treatment for mothers enrolled in the different perinatal and maternal HIV prevention and treatment trials at MU-JHU.
He served as co-director and senior mentor for the Stephen Lewis funded mentorship program_ providing mentorship in HIV care and treatment to health care providers across Africa
He is currently the Investigator of Record for IMPAACT 1026s, the pharmacokinetics of antiretroviral and TB drugs in HIV infected pregnant women as well as Investigator of Record for IMPAACT 2010; Dolutegravir for prevention of mother to child HIV transmission.